Search Results for

Showing 1 - 10 of 50 results
  1. Organizers

    Organizers Meeting Organizers Champalimaud Foundation Scientific Program Liaison Guests of Honor Sponsors

  2. Invited speakers

    Invited speakers Bettina Ryll Richard D. Carvajal Invited Speakers Sponsors

  3. Organizers

    Organizers Conference Organizers Committee Members

  4. Housing and registration

    Registration and housing Registration Rates shown in U.S. dollars   Early bird rate Advance rate Onsite rate   Through June 8  Through July 6      After July 6 Regular attendee $449 $495 $515 Student attendee*      $249 $295 $315  *Students are undergraduate and graduate students, post-graduate fellows, medical students, optometry students and residents. Registration includes: 2.5 days of programming Coffee breaks, two lunches, one opening reception Champalima

  5. Future Annual Meetings

    Future Annual Meetings   Year      Date      Location      Visitor information      2019   April 28 - May 2   Vancouver, Canada   What to do in Vancouver   2020   May 3 - 7     Baltimore, Md.   Visit  Baltimore      2021   May 2 - 6     San Francisco, Calif.   San Francisco Travel        2022   May 1 - 5   Denver, Colo.   Visit Denver   2023   April 23 - 27    New Orleans, Louisiana   Visit New Orleans   2024   May 5 - 9   Seattle, Wash.   Visit Seat

  6. Program

    Program Conference program The conference program includes podium sessions, with opening and closing keynote lectures, a tour of the Champalimaud Centre for the Unknown, poster sessions and multiple opportunities for attendees to network. Speakers are international experts in oncogenesis and oncology, from the Champalimaud Centre for the Unknown and other ophthalmic centers around the globe.  Program schedule overview Wednesday, July 18 – afternoon registration hours (Attendees may also chec

  7. Abstracts

    Abstracts The Ocular Oncogenesis and Oncology organizers seeks high-quality abstracts describing original, unpublished research results that contain a clear statement of hypothesis, an explanation of methods, a report of data that unequivocally test the hypothesis, and a brief discussion of their implications. Abstract submission is now closed. First authors were notified on April 20, 2018. For questions about abstracts, please send inquiries to: ooo@arvo.org or call 240.221.2900. Abstract